Despite limitations to this approach, we have identified several single agents that are highly cytotoxic to EFT cells, and morpholino cocktails targeting PHGDH transcripts, in combination with XAGE1 or CYP4F22, may be highly synergistic across multiple EFT tumor types. The gene discussed is XAGE1B; the disease is neoplasm.